abstract |
siRNA against hepatitis B virus (HBV), and a siRNA conjugate. Specifically provided are siRNA targeting a HBV genome, a siRNA conjugate, a composition, and medical use thereof. Also provided are a pharmaceutical composition, cell, or kit comprising the siRNA, and a method for using the siRNA for treatment and/or prevention of HBV infection or a HBV-related disease in a subject. |